RNAimmune
JiaXi JiaXi has worked in various medical roles since 2016. JiaXi began their career as a PhD. M.D. at Guangzhou Medical University 1st Affiliated Hospital in 2016. JiaXi then moved to the University of Maryland School of Medicine in 2019, where they served as a Postdoctoral Research Fellow. Most recently, in 2022, they became the Section Chief Medical Officer at RNAimmune.
JiaXi JiaXi received a Doctor of Philosophy (Ph.D.) in Medicine from Guangzhou Medical College between 2013 and 2016. JiaXi obtained a Master's degree in Medicine from Sun Yat-sen University between 2009 and 2012, and a Bachelor's degree in Medicine from the same university between 2004 and 2009.
This person is not in any teams
This person is not in any offices
RNAimmune
RNAimmune is a biotechnology startup in the field of messenger RNA (mRNA) technology with more than 20 years’ expertise in handling and optimizing this versatile molecule for medical purposes. The principle of RNAimmune's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. The company applies its technologies for the development of cancer therapies, antibody therapies, the treatment of rare diseases, and prophylactic vaccines.